OptimizeRx Corporation and Simulmedia Announce Strategic Partnership to Transform Healthcare Advertising with Precision Targeting on TV and Streaming Platforms

Reuters
2025/06/18
<a href="https://laohu8.com/S/OPRX">OptimizeRx Corporation</a> and Simulmedia Announce Strategic Partnership to Transform Healthcare Advertising with Precision Targeting on TV and Streaming Platforms

Simulmedia, a leader in data-driven TV and streaming advertising, has announced a strategic partnership with OptimizeRx Corporation, a prominent provider of healthcare technology solutions. This collaboration introduces the availability of Micro-Neighborhood® Targeting (MNT) audiences across linear, digital, and connected TV channels. The partnership enables healthcare brands, particularly small and mid-size pharmaceutical companies, to activate precise audiences through guaranteed premium TV and streaming inventory with programmatic advertising speed and flexibility. The collaboration addresses industry challenges in linear TV media buying, offering rapid deployment of data-driven campaigns, real-time adjustments, and predictive spot-level placements. This strategic alliance aims to transform how healthcare marketers engage patients and providers throughout the care journey.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250618159849) on June 18, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10